The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol



Millard, James D ORCID: 0000-0001-6427-552X, Mackay, Elizabeth A, Bonnett, Laura J ORCID: 0000-0002-6981-9212 and Davies, Geraint R
(2019) The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol. SYSTEMATIC REVIEWS, 8 (1).

This is the latest version of this item.

[img] Text
PZA dose systematic review - revised_CLEAN.docx - Accepted Version

Download (63kB)
[img] Text
s13643-019-1231-1.pdf - Published Version

Download (516kB) | Preview
Item Type: Article
Uncontrolled Keywords: Tuberculosis, Clinical trials, Pyrazinamide, Efficacy, Toxicity, Safety
Depositing User: Symplectic Admin
Date Deposited: 13 Jan 2020 10:09
Last Modified: 27 Nov 2020 22:10
DOI: 10.1186/s13643-019-1231-1
Open Access URL: https://doi.org/10.1186/s13643-019-1231-1
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3070434

Available Versions of this Item